COVID-19 epidemiological, sociological and anthropological investigation: study protocol for a multidisciplinary mixed methods research in Burkina Faso.

COVID-19 Clinical epidemiology Predictive score SARS-CoV-2 Sero-epidemiology Socio-anthropology

Journal

BMC infectious diseases
ISSN: 1471-2334
Titre abrégé: BMC Infect Dis
Pays: England
ID NLM: 100968551

Informations de publication

Date de publication:
03 Sep 2021
Historique:
received: 14 06 2021
accepted: 06 08 2021
entrez: 4 9 2021
pubmed: 5 9 2021
medline: 25 9 2021
Statut: epublish

Résumé

The world has high hopes of vaccination against COVID-19 to protect the population, boost economies and return to normal life. Vaccination programmes are being rolled out in high income countries, but the pandemic continues to progress in many low-and middle-income countries (LMICs) despite implementation of strict hygiene measures. We aim to present a comprehensive research protocol that will generate epidemiological, sociological and anthropological data about the COVID-19 epidemic in Burkina Faso, a landlocked country in West Africa with scarce resources. We will perform a multidisciplinary research using mixed methods in the two main cities in Burkina Faso (Ouagadougou and Bobo-Dioulasso). Data will be collected in the general population and in COVID-19 patients, caregivers and health care professionals in reference care centers: (i) to determine cumulative incidence of SARS-CoV-2 infection in the Burkinabe population using blood samples collected from randomly selected households according to the WHO-recommended protocol; (ii) develop a score to predict severe complications of COVID-19 in persons infected with SARS-CoV-2 using retrospective and prospective data; (iii) perform semi-structured interviews and direct observation on site, to describe and analyze the healthcare pathways and experiences of patients with COVID-19 attending reference care centers, and to identify the perceptions, acceptability and application of preventive strategies among the population. This study will generate comprehensive data that will contribute to improving COVID-19 response strategies in Burkina Faso. The lessons learned from the management of this epidemic may serve as examples to the country authorities to better design preventive strategies in the case of future epidemics or pandemics. The protocol was approved by the Ministry for Health (N° 2020-00952/MS/CAB/INSP/CM) and the Health Research Ethics Committee in Burkina Faso (N° 2020-8-140).

Sections du résumé

BACKGROUND BACKGROUND
The world has high hopes of vaccination against COVID-19 to protect the population, boost economies and return to normal life. Vaccination programmes are being rolled out in high income countries, but the pandemic continues to progress in many low-and middle-income countries (LMICs) despite implementation of strict hygiene measures. We aim to present a comprehensive research protocol that will generate epidemiological, sociological and anthropological data about the COVID-19 epidemic in Burkina Faso, a landlocked country in West Africa with scarce resources.
METHODS METHODS
We will perform a multidisciplinary research using mixed methods in the two main cities in Burkina Faso (Ouagadougou and Bobo-Dioulasso). Data will be collected in the general population and in COVID-19 patients, caregivers and health care professionals in reference care centers: (i) to determine cumulative incidence of SARS-CoV-2 infection in the Burkinabe population using blood samples collected from randomly selected households according to the WHO-recommended protocol; (ii) develop a score to predict severe complications of COVID-19 in persons infected with SARS-CoV-2 using retrospective and prospective data; (iii) perform semi-structured interviews and direct observation on site, to describe and analyze the healthcare pathways and experiences of patients with COVID-19 attending reference care centers, and to identify the perceptions, acceptability and application of preventive strategies among the population.
DISCUSSION CONCLUSIONS
This study will generate comprehensive data that will contribute to improving COVID-19 response strategies in Burkina Faso. The lessons learned from the management of this epidemic may serve as examples to the country authorities to better design preventive strategies in the case of future epidemics or pandemics. The protocol was approved by the Ministry for Health (N° 2020-00952/MS/CAB/INSP/CM) and the Health Research Ethics Committee in Burkina Faso (N° 2020-8-140).

Identifiants

pubmed: 34479501
doi: 10.1186/s12879-021-06543-4
pii: 10.1186/s12879-021-06543-4
pmc: PMC8414025
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

896

Subventions

Organisme : Agence Nationale de Recherches sur le Sida et les Hépatites Virales
ID : ANRS-COV13 / EMuLCOVID-19
Organisme : Institute of Population and Public Health
ID : CIHR-IRSC:0579001152

Informations de copyright

© 2021. The Author(s).

Références

Clin Infect Dis. 2020 Nov 19;71(16):2027-2034
pubmed: 32221519
J Postgrad Med. 2001 Jan-Mar;47(1):45-50
pubmed: 11590294
N Engl J Med. 2020 Mar 26;382(13):1199-1207
pubmed: 31995857
Euro Surveill. 2020 Jan;25(3):
pubmed: 31992387
MMWR Morb Mortal Wkly Rep. 2021 Mar 05;70(9):329-332
pubmed: 33661860
Ann Palliat Med. 2020 Mar;9(2):428-436
pubmed: 32233642
JAMA Intern Med. 2020 Jul 1;180(7):934-943
pubmed: 32167524
Biosci Trends. 2020 Mar 16;14(1):72-73
pubmed: 32074550
Int J Antimicrob Agents. 2020 Mar;55(3):105924
pubmed: 32081636
Int J Antimicrob Agents. 2020 Jul;56(1):105949
pubmed: 32205204
Nature. 2020 Mar;579(7798):265-269
pubmed: 32015508

Auteurs

Isidore Tiandiogo Traoré (IT)

Centre MURAZ, Institut National de Santé Publique, Bobo-Dioulasso, Burkina Faso.
Institut Supérieur Des Sciences de la Santé, Université Nazi Boni, Bobo-Dioulasso, Burkina Faso.

Samiratou Ouedraogo (S)

Institut National de Santé Publique du Québec, Montréal, QC, Canada. samioued@yahoo.fr.
The Department of Epidemiology, Biostatistics and Occupational Health, Faculty of Medicine, McGill University, Montreal, QC, Canada. samioued@yahoo.fr.
Observatoire National de la Santé de la Population, Institut National de Santé Publique, Ouagadougou, Burkina Faso. samioued@yahoo.fr.

Dramane Kania (D)

Centre MURAZ, Institut National de Santé Publique, Bobo-Dioulasso, Burkina Faso.

Firmin Nongodo Kaboré (FN)

Centre MURAZ, Institut National de Santé Publique, Bobo-Dioulasso, Burkina Faso.

Blahima Konaté (B)

Département de Socio-Économie et d'Anthropologie du Développement, Institut des Sciences des Sociétés - Centre National de la Recherche Scientifique et Technologique, Ouagadougou, Burkina Faso.

Rachel Médah (R)

Centre MURAZ, Institut National de Santé Publique, Bobo-Dioulasso, Burkina Faso.

Hermann Badolo (H)

Observatoire National de la Santé de la Population, Institut National de Santé Publique, Ouagadougou, Burkina Faso.

Nathalie de Rekeneire (N)

Centre MURAZ, Institut National de Santé Publique, Bobo-Dioulasso, Burkina Faso.
Expertise France, Paris, France.

Ariane Mamguem Kamga (AM)

Epidemiology and Quality of Life Research Unit, INSERM U1231, Georges Francois Leclerc Centre - UNICANCER, Dijon, France.

Armel Poda (A)

Centre MURAZ, Institut National de Santé Publique, Bobo-Dioulasso, Burkina Faso.
Institut Supérieur Des Sciences de la Santé, Université Nazi Boni, Bobo-Dioulasso, Burkina Faso.
Service des Maladies Infectieuses, Centre Hospitalier Universitaire Sourô Sanou, Bobo Dioulasso, Burkina Faso.

Arnaud Eric Diendere (AE)

Centre Hospitalier Universitaire de Bogodogo, Ouagadougou, Burkina Faso.

Boukary Ouédraogo (B)

Direction des Systèmes d'information en Santé, ministère de la santé, Ouagadougou, Burkina Faso.

Esperance Ouédraogo (E)

Département de Médicine, pharmacopée traditionnelle et pharmacie, Institut de Recherche en Sciences de la Santé - Centre National de la Recherche Scientifique et Technologique, Ouagadougou, Burkina Faso.

Oumar Billa (O)

Epidemiology and Quality of Life Research Unit, INSERM U1231, Georges Francois Leclerc Centre - UNICANCER, Dijon, France.

Halidou Tinto (H)

Centre MURAZ, Institut National de Santé Publique, Bobo-Dioulasso, Burkina Faso.
Institut de Recherche en Sciences de la Santé, Centre National de la Recherche Scientifique et Technologique, Ouagadougou, Burkina Faso.

Tienhan Sandrine Dabakuyo-Yonli (TS)

Epidemiology and Quality of Life Research Unit, INSERM U1231, Georges Francois Leclerc Centre - UNICANCER, Dijon, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH